Innovent Biologics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SZSC:1801 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
02 Feb 24	BuyHK$60,788,476	Capital Research and Management Company	Company	1,869,776	HK$32.51
12 Jan 24	BuyHK$51,892,586	Capital Research and Management Company	Company	1,292,500	HK$40.15
05 Jan 24	SellHK$133,714,368	Capital Research and Management Company	Company	3,456,000	HK$38.69
25 Oct 23	BuyHK$103,314,132	Capital Research and Management Company	Company	2,249,500	HK$45.93
17 Oct 23	SellHK$22,237,564	De-Chao Yu	Individual	502,961	HK$44.21
12 Oct 23	SellHK$143,016,662	Capital Research and Management Company	Company	3,324,500	HK$43.02
21 Sep 23	SellHK$877,219,533	JPMorgan Chase & Co, Brokerage and Securities Investments	Company	23,185,276	HK$37.84
12 Sep 23	BuyHK$908,012,098	JPMorgan Chase & Co, Brokerage and Securities Investments	Company	25,518,000	HK$35.58
16 Jun 23	SellHK$44,415,982	SDIC Innovation Investment Management Co., Ltd.	Company	1,271,000	HK$34.95
29 May 23	BuyHK$73,245,650	Capital Research and Management Company	Company	2,007,500	HK$36.49
11 May 23	BuyHK$33,091,801	SDIC Innovation Investment Management Co., Ltd.	Company	837,500	HK$39.51

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 1801?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	10,614,500	0.654%
VC/PE Firms	89,475,350	5.51%
Individual Insiders	113,380,716	6.99%
General Public	676,924,209	41.7%
Institutions	732,288,122	45.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.6%.

Top Shareholders

Top 25 shareholders own 49.94% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.04%	Capital Research and Management Company	114,164,873	HK$4.7b	16.1%	0.03%
6.73%	De-Chao Yu	109,245,165	HK$4.5b	0.34%	no data
5.51%	SDIC Innovation Investment Management Co., Ltd.	89,475,350	HK$3.7b	0%	30.09%
3.56%	The Vanguard Group, Inc.	57,837,849	HK$2.4b	1.14%	0.01%
3.41%	Eli Lilly Investment Consulting (Shanghai) Co., Ltd.	55,364,540	HK$2.3b	0%	46.48%
2.65%	BlackRock, Inc.	42,985,196	HK$1.8b	20.2%	no data
2.25%	Temasek Holdings (Private) Limited	36,535,000	HK$1.5b	0%	0.2%
2.06%	E Fund Management Co., Ltd.	33,453,000	HK$1.4b	0%	0.26%
1.86%	Fidelity International Ltd	30,112,499	HK$1.2b	-0.09%	0.07%
1.67%	GF Fund Management Co., Ltd.	27,097,655	HK$1.1b	0%	0.35%
1.66%	Canada Pension Plan Investment Board	27,004,000	HK$1.1b	0%	0.1%
1.6%	Harvest Fund Management Co. Ltd.	25,928,788	HK$1.1b	30.9%	0.41%
1.54%	Citigroup Inc.,Banking and Securities Investments	24,932,063	HK$1.0b	0%	0.13%
1.39%	FMR LLC	22,608,544	HK$924.7m	19.7%	0.01%
1.06%	Bosera Asset Management Co., Ltd.	17,206,500	HK$703.7m	0%	0.5%
0.92%	Norges Bank Investment Management	14,999,175	HK$613.5m	-20.8%	0.01%
0.88%	Lav Advanced Management Company Limited	14,276,500	HK$583.9m	0%	71.94%
0.63%	China Asset Management Co. Ltd.	10,165,139	HK$415.8m	-2.3%	0.08%
0.56%	RBC Global Asset Management Inc.	9,115,794	HK$372.8m	44,700%	0.03%
0.54%	Schroder Investment Management Limited	8,747,500	HK$357.8m	0%	0.03%
0.51%	Strategic Advisers LLC	8,351,784	HK$341.6m	76.8%	0.02%
0.5%	Invesco Ltd.	8,191,500	HK$335.0m	-0.84%	0.01%
0.47%	Polar Capital Holdings Plc	7,655,875	HK$313.1m	0%	0.18%
0.46%	Schroder Investment Management North America Inc.	7,531,000	HK$308.0m	28.3%	0.13%
0.45%	LAV Investment Adviser Limited	7,345,000	HK$300.4m	0%	no data